Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. ZION
ZION logo

ZION Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Zions Bancorporation NA (ZION) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
54.850
1 Day change
-1.03%
52 Week Range
66.170
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Zions Bancorporation NA (ZION) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock has shown recent negative price momentum, insider selling activity, and no immediate strong trading signals. While the company's financial performance in Q4 2025 was solid, with significant growth in net income and EPS, the technical indicators and trading sentiment do not suggest an optimal entry point right now. Waiting for a clearer positive trend or a stronger catalyst would be more prudent.

Technical Analysis

The MACD is negative and expanding (-0.605), indicating bearish momentum. RSI is at 27.326, suggesting the stock is nearing oversold territory but not yet providing a clear buy signal. Moving averages are converging, showing no strong directional trend. The price is currently near the S1 support level of 55.228, but with no clear upward momentum.

Options Data

Neutral
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The put-call ratios indicate a slightly bullish sentiment in the options market, with higher call volume relative to puts. However, implied volatility is high (47.25), suggesting uncertainty.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
5

Positive Catalysts

  • Morgan Stanley's recent upgrade to Overweight with a price target of $75 highlights potential future profitability and stock buybacks. The company's Q4 2025 financials showed strong growth in net income (up 30.81%) and EPS (up 31.34%).

Neutral/Negative Catalysts

  • Insider selling has increased significantly (2580.60% over the last month), which may indicate a lack of confidence from within the company. The stock has underperformed in 2026 and is down 3.03% in regular trading and 4.31% in pre-market trading. Technical indicators suggest bearish momentum.

Financial Performance

In Q4 2025, revenue increased by 0.88% YoY to $801M, net income rose by 30.81% YoY to $259M, and EPS grew by 31.34% YoY to $1.76. These results indicate strong profitability and operational efficiency.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have mixed views. Morgan Stanley upgraded the stock to Overweight with a $75 price target, citing positive operating leverage. However, other firms like Baird and UBS maintain Neutral ratings, citing balanced risk/reward and asset sensitivity concerns. Recent price target updates range from $63 to $75, showing moderate optimism but no unanimous bullish sentiment.

Wall Street analysts forecast ZION stock price to rise
21 Analyst Rating
Wall Street analysts forecast ZION stock price to rise
4 Buy
16 Hold
1 Sell
Hold
Current: 55.420
sliders
Low
58
Averages
64
High
70
Current: 55.420
sliders
Low
58
Averages
64
High
70
Baird
David George
Neutral -> Outperform
upgrade
$65
AI Analysis
2026-03-09
New
Reason
Baird
David George
Price Target
$65
AI Analysis
2026-03-09
New
upgrade
Neutral -> Outperform
Reason
Baird analyst David George upgraded Zions Bancorp to Outperform from Neutral with an unchanged price target of $65. The firm believes the recent weakness in bank socks creates more attractive risk/reward trade-offs. There is a "margin of safety" in many regional banks at current prices, as capital is in good shape and credit trends are solid, the analyst tells investors in a research note. Baird believes now is a good time to add to or take positions in bank regionals. It upgraded three names and added a "Fresh Pick designation" on Huntington Bancshares.
Morgan Stanley
Equal Weight -> Overweight
upgrade
$70 -> $75
2026-03-02
Reason
Morgan Stanley
Price Target
$70 -> $75
2026-03-02
upgrade
Equal Weight -> Overweight
Reason
Morgan Stanley upgraded Zions Bancorp to Overweight from Equal Weight with a price target of $75, up from $70. The firm expects 180 basis points of positive operating leverage for the bank in 2026, above both the company's guidance and the 90 points consensus estimate. In addition, the stock has underperformed the group in 2026, making for an attractive entry point, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ZION
Unlock Now

People Also Watch